120 related articles for article (PubMed ID: 22425015)
41. Presumed previous human papillomavirus (HPV) related gynecological cancer in women diagnosed with anal cancer in the province of Ontario.
Jiménez W; Paszat L; Kupets R; Wilton A; Tinmouth J
Gynecol Oncol; 2009 Sep; 114(3):395-8. PubMed ID: 19501390
[TBL] [Abstract][Full Text] [Related]
42. Viral-associated nonmelanoma skin cancers: a review.
Dubina M; Goldenberg G
Am J Dermatopathol; 2009 Aug; 31(6):561-73. PubMed ID: 19590418
[TBL] [Abstract][Full Text] [Related]
43. Prevention of recurrent high-grade anal neoplasia with quadrivalent human papillomavirus vaccination of men who have sex with men: a nonconcurrent cohort study.
Swedish KA; Factor SH; Goldstone SE
Clin Infect Dis; 2012 Apr; 54(7):891-8. PubMed ID: 22291111
[TBL] [Abstract][Full Text] [Related]
44. Human papillomavirus vaccine for genotypes 6, 11, 16 and 18: new drug. Cervical cancer prevention: high hopes...
Prescrire Int; 2007 Jun; 16(89):91-4. PubMed ID: 17582921
[TBL] [Abstract][Full Text] [Related]
45. Improvement of Gynecological Screening of Female Renal Transplant Recipients by Self-Sampling for Human Papillomavirus Detection.
Hinten F; Hilbrands LB; Meeuwis KA; van Bergen-Verkuyten MC; Slangen BF; van Rossum MM; Rahamat-Langendoen J; Massuger LF; de Hullu JA; Melchers WJ
J Low Genit Tract Dis; 2017 Jan; 21(1):33-36. PubMed ID: 27741039
[TBL] [Abstract][Full Text] [Related]
46. Human papillomavirus infection and anal dysplasia in renal transplant recipients.
Patel HS; Silver AR; Levine T; Williams G; Northover JM
Br J Surg; 2010 Nov; 97(11):1716-21. PubMed ID: 20730855
[TBL] [Abstract][Full Text] [Related]
47. Cervicovaginal HPV infection in female renal transplant recipients: an observational, self-sampling based, cohort study.
Meeuwis KA; Hilbrands LB; IntHout J; Slangen BF; Hendriks IM; Hinten F; Christiaans MH; Quint WG; van de Kerkhof PC; Massuger LF; Hoitsma AJ; van Rossum MM; Melchers WJ; de Hullu JA
Am J Transplant; 2015 Mar; 15(3):723-33. PubMed ID: 25675976
[TBL] [Abstract][Full Text] [Related]
48. Anogenital premalignant and malignant tumors (including Buschke-Löwenstein tumors).
Grussendorf-Conen EI
Clin Dermatol; 1997; 15(3):377-88. PubMed ID: 9255444
[No Abstract] [Full Text] [Related]
49. Comparison of Long-Term Outcomes of Surgical Treatment of Human Papillomavirus-Dependent Neoplastic Lesions in Patients With Chronic Immunosuppression After Allogenic Organ Transplantation and Patients With Primary or Acquired Immunodeficiency-A One-Center Experience.
Prokop P; Bartoszewicz M; Gardyszewska A; Kosieradzki M; Fiedor P
Transplant Proc; 2024 May; 56(4):953-956. PubMed ID: 38734517
[TBL] [Abstract][Full Text] [Related]
50. [Giant anogenital condyloma in an HIV-infected Gabonese woman].
Ondounda M; Pither Antchoue S; Zamba C
Med Sante Trop; 2012; 22(1):12. PubMed ID: 22868719
[No Abstract] [Full Text] [Related]
51. A unique verrucous anogenital tumor associated with type 6b-related human papillomavirus.
Nakajima T; Yutsudo M; Ikekawa S; Hayasaka K; Ishihara K; Gotoh M; Shimosato Y; Tsunokawa Y; Terada M
Acta Pathol Jpn; 1989 Aug; 39(8):528-32. PubMed ID: 2554664
[TBL] [Abstract][Full Text] [Related]
52. Prevalence, type distribution and risk factors for oral HPV in Danish renal transplant recipients.
Faber MT; Kjaer AK; Larsen HK; Thomsen LT; Haedersdal M; Bonde J; Hansen JM; Sørensen SS; Kjaer SK
Oral Dis; 2020 Mar; 26(2):484-488. PubMed ID: 31742827
[TBL] [Abstract][Full Text] [Related]
53. When rectal bleeding is serious: anal squamous cell carcinoma in two intravenous cyclophosphamide treated systemic lupus erythematosus patients with human papilloma virus infection.
Lydon EJ; Belmont HM
Lupus; 2013 Oct; 22(11):1182-4. PubMed ID: 23893826
[TBL] [Abstract][Full Text] [Related]
54. Renal allograft recipients with high susceptibility to cutaneous malignancy have an increased prevalence of human papillomavirus DNA in skin tumours and a greater risk of anogenital malignancy.
Arends MJ; Benton EC; McLaren KM; Stark LA; Hunter JA; Bird CC
Br J Cancer; 1997; 75(5):722-8. PubMed ID: 9043031
[TBL] [Abstract][Full Text] [Related]
55. Reactivation of Latent HPV Infections After Renal Transplantation.
Hinten F; Hilbrands LB; Meeuwis KAP; IntHout J; Quint WGV; Hoitsma AJ; Massuger LFAG; Melchers WJG; de Hullu JA
Am J Transplant; 2017 Jun; 17(6):1563-1573. PubMed ID: 28009475
[TBL] [Abstract][Full Text] [Related]
56. Anogenital distribution of mucosal HPV in males and females before and after renal transplantation.
Prétet JL; Touzé A; Pazart L; Boiteux G; Fournier V; Vidal C; Arnold F; Ducloux D; Lepiller Q; Mougin C
Infect Dis Now; 2024 Feb; 54(1):104830. PubMed ID: 37949172
[TBL] [Abstract][Full Text] [Related]
57. Correlation of Cancer Development and Human Papilloma Virus Infection in Patients After Organ Transplantation.
Suwalska A; Smolarczyk K; Kosieradzki M; Fiedor P
Transplant Proc; 2020 Sep; 52(7):1982-1984. PubMed ID: 32474002
[TBL] [Abstract][Full Text] [Related]
58. Human papillomavirus-related cancer risk for solid organ transplant recipients during adult life and early prevention strategies during childhood and adolescence.
Nailescu C; Ermel AC; Shew ML
Pediatr Transplant; 2022 Nov; 26(7):e14341. PubMed ID: 35808949
[TBL] [Abstract][Full Text] [Related]
59. Is It Time for Risk-based Screening Guidelines for the Prevention of Anal Cancer?
Castle PE
Clin Infect Dis; 2021 Jul; 73(1):30-32. PubMed ID: 32544237
[No Abstract] [Full Text] [Related]
60. Introduction: HPV Related Malignancies.
Chera BS
Semin Radiat Oncol; 2021 Oct; 31(4):263-264. PubMed ID: 34455981
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
